Canada Castrate Resistant Prostate Cancer Therapeutics Market Analysis

Canada Castrate Resistant Prostate Cancer Therapeutics Market Analysis


$ 3999

Canada Castrate Resistant Prostate Cancer Therapeutics Market valued at $816 Mn in 2022, projected to reach $1413 Mn by 2030 with a 7.10% CAGR. The key drivers of growth include the persistent unmet medical need for a cure, which fuels extensive research and development efforts for innovative treatments, as well as the transformative impact of technological innovations such as precision medicine, and a shift towards patient-centric priorities focusing on improved quality of life and less intrusive treatment options. The Canada Castrate Resistant Prostate Cancer Therapeutics Market encompasses various players across different segments, including Pfizer, Johnson & Johnson, Bayer, Roche, Sanofi, Novartis, AstraZeneca, Apotex, Paladin Labs, Bausch etc, among various others.

ID: IN10CAPH444 CATEGORY: Pharmaceuticals GEOGRAPHY: Canada AUTHOR: Dr. Netal Patel

Buy Now

Canada Castrate Resistant Prostate Cancer Therapeutics Market Analysis Executive Summary

Canada Castrate Resistant Prostate Cancer Therapeutics Market valued at $816 Mn in 2022, projected to reach $1413 Mn by 2030 with a 7.10% CAGR.

Castration-resistant prostate cancer (CRPC) refers to advanced prostate cancer that no longer responds to hormonal therapies designed to lower testosterone levels. Despite early interventions like surgical castration or androgen deprivation therapy (ADT), CRPC can develop, leading to disease progression. The causes of CRPC are diverse and not fully understood, involving factors such as the development of resistance mechanisms in cancer cells, genetic abnormalities, alterations in androgen receptor signaling, and changes in the tumor microenvironment. Treatment options for CRPC encompass chemotherapy, immunotherapy, and advanced hormonal therapies. Chemotherapeutic agents like docetaxel and cabazitaxel are commonly used, and immunotherapies, such as sipuleucel-T, aim to stimulate the immune system against cancer cells. Recent advances include second-generation anti-androgen drugs like enzalutamide and abiraterone acetate, targeting the androgen receptor and testosterone synthesis, respectively. Ongoing research explores novel strategies like immunotherapies and precision medicine, offering hope for improved outcomes and a higher quality of life for individuals with CRPC.

In Canada, 1 in 8 men are estimated to eventually have prostate cancer, and of them, 10–20% are likely to develop CRPC within 5 years of diagnosis. After the age of fifty, the risk increases considerably. But this can vary based on things like age, diagnostic stage, and course of therapy.

The key drivers of growth include the persistent unmet medical need for a cure, which fuels extensive research and development efforts for innovative treatments, as well as the transformative impact of technological innovations such as precision medicine, and a shift towards patient-centric priorities focusing on improved quality of life and less intrusive treatment options.

Strong R&D investments for innovative CRPC medicines are made by Pfizer, Johnson & Johnson, Roche, and other companies, demonstrating their dedication to this market. Roche's potential reach is increased by the promising immunotherapy and radiopharmaceutical compounds in its pipeline.

Canada castrate resistant prostrate cancer therapeutics market

Market Dynamics

Market Growth Drivers

Changing Medical Treatment Environment and Unmet Medical Needs: Although life expectancy has increased with available treatments such as androgen deprivation therapy, CRPC is still incurable. Extensive research and development (R&D) for innovative treatment alternatives is motivated by this unmet medical need. At the forefront are immunotherapies, radiopharmaceuticals, and targeted treatments, which provide promise for more powerful and maybe curative approaches.

Innovation is Driven by Technological Innovations: The field of CRPC is undergoing a revolution thanks to tailored treatment plans and precision medicine. The creation of medicines customized to the genetic profiles and tumor features of specific patients is made possible by advancements in genomics and biomarkers. Comparing tailored medicines to more conventional, broad-spectrum medications, there is great potential for increased efficacy and fewer adverse effects.

Patient-Centric Priorities and Quality-of-Life Issues: The paradigm for therapy is fast shifting as a result of the emphasis on quality of life and patient-centric outcomes. More and more, contemporary treatments seek to provide less intrusive procedures, reduce side effects, and increase survival rates. The development of focused, individualized, and less disruptive treatment alternatives is being fuelled by the emphasis on patient well-being and overall quality of life, which is resulting in a more comprehensive approach to managing colorectal cancer.

Market Restraints

Exorbitant Treatment Costs and Waiting Times: One major obstacle is the cost of CRPC treatments, which are rather high. Exorbitant expenses can restrict patient access, put pressure on healthcare resources, and create financial difficulties for both patients and the healthcare system. Furthermore, Prolonged waiting periods before starting CRPC treatment can make it more difficult to intervene promptly, which could worsen patient outcomes and cause the condition to advance. Obstacles in the healthcare system and limited resources might be blamed for delays in receiving novel treatments.

Existence of Established Players: There may be obstacles for more recent entrants and less competition in the CRPC therapeutics market due to the dominance of established pharmaceutical corporations. It can be difficult for smaller or more recent businesses to achieve momentum since established firms frequently have strong market positions, ample resources, and established contacts.

Small Market Size: Compared to larger markets, Canada's CRPC therapy market is comparatively smaller, which can reduce pharmaceutical companies' incentives to spend. The availability of a wider range of treatment alternatives may be impacted by fewer research and development activities as a result of the smaller patient population.

Healthcare Policies and Regulatory Landscape

Canada has a publicly financed healthcare system that guarantees access to basic medical treatments, including hospitalization, for all citizens. Health Canada's Therapeutic Products Directorate is responsible for overseeing and regulating pharmaceuticals and medical equipment to guarantee their efficacy and safety (TPD). The TPD is in charge of assessing and approving medications and medical devices for use in Canada in addition to maintaining continuous post-market safety surveillance. Pharmaceutical businesses apply to Health Canada, especially the TPD, in order to bring a new drug to the Canadian market. In this application, they provide extensive information on animal research, chemistry, manufacturing procedures, and clinical trial findings. Before approving a medicine or medical equipment for use in Canada, the TPD carefully examines, verifies, and oversees its safety.

Competitive Landscape

Key Players:

  • Pfizer
  • Johnson & Johnson
  • Bayer
  • Roche
  • Sanofi
  • Novartis
  • AstraZeneca
  • Apotex
  • Paladin Labs
  • Bausch

1. Executive Summary
1.1 Disease Overview
1.2 Global Scenario
1.3 Country Overview
1.4 Healthcare Scenario in Country
1.5 Patient Journey
1.6 Health Insurance Coverage in Country
1.7 Active Pharmaceutical Ingredient (API)
1.8 Recent Developments in the Country

2. Market Size and Forecasting
2.1 Epidemiology of Disease
2.2 Market Size (With Excel & Methodology)
2.3 Market Segmentation (Check all Segments in Segmentation Section)

3. Market Dynamics
3.1 Market Drivers
3.2 Market Restraints

4. Competitive Landscape
4.1 Major Market Share

4.2 Key Company Profile (Check all Companies in the Summary Section)

4.2.1 Company
4.2.1.1 Overview
4.2.1.2 Product Applications and Services
4.2.1.3 Recent Developments
4.2.1.4 Partnerships Ecosystem
4.2.1.5 Financials (Based on Availability)

5. Reimbursement Scenario
5.1 Reimbursement Regulation
5.2 Reimbursement Process for Diagnosis
5.3 Reimbursement Process for Treatment

6. Methodology and Scope

Canada Castrate Resistant Prostate Cancer Therapeutics Market Segmentation

By Route

  • Parenteral Route
  • Oral Route
  • Others

By Therapy

  • Hormone Therapy
  • Chemotherapy
  • Immunotherapy
  • Radiotherapy

By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

By End User

  • Hospitals
  • Specialty Clinics
  • Homecare
  • Academics & Research Centers
  • Others

Insights10 will provide you with the reports within 10 key parameters which are:

  1. Market Overview
  2. Market Growth Drivers & Restraints
  3. Epidemiology of Disease Type
  4. Market Segmentation
  5. Market Share
  6. Competitive Landscape
  7. Key Company Profiles
  8. Healthcare Policies & Regulatory Framework
  9. Reimbursement Scenario
  10. Factors Driving Future Growth

Based on our many years of experience, we believe that these are the parameters that are critical to decision-making for business stakeholders. Our focused approach to developing reports focused on 10 key parameters, enabled us to arrive at the name “Insights10”.

 

Stage I: Market Data Collection

Primary Interviews: We have developed a network of experts, freelancers, and researchers across countries through which we engage with local experts to gather key data points and assumptions about each market. We also engage regularly with some of the best market research agencies such as Atheneum, GuidePoint, GLG, etc. to conduct surveys and interviews, and build intelligence. We have language translators as a part of our team, who between them can cover 30+ languages allowing us to extract better local insights.

Secondary Data Collection: We have developed strong expertise and experience in secondary data collection methods for developing unique data sets and research material. We gather data from multiple reliable sources to maintain a high level of accuracy and consistency. The market data is analyzed and forecasted using appropriate statistical and coherent models. The report offers an overall analysis of the market size, growth, and market share as well as a segment-level analysis of the specific market. Our report includes precise, to-the-point information related to the overall market, competition, growth drivers, challenges, regulatory updates, and competition.

Data Sources: We have access to multiple highly reliable free and subscription data sources. We have many years of experience to understand which sources are more dependable for what and which to prefer for the reliable and latest information. The key sources of information include the following, but are not limited to:

 

 

Stage II: Market Data Analysis and Statistical Model

Market Trends: We generally look at macro parameters and micro indicators. The macro parameters include changes in government policies, demand and supply of the market, government intervention programs, and major market share. The micro indicators are GDP growth, market size, market volume, etc. We also understand nuances specific to each country like the US, Canada, India, Germany, etc., and have worked across 60+ countries and hence not only understand global trends but how these differ by country, how payment models, market structure, cultural parameters, etc. differ in each country.

Market Sizing and Analysis: Our expert data analytics team has created various market forecast models by employing the top-down approach i.e. starting with the large overall market and segmenting different areas and the bottom-up approach i.e. starting with population and epidemiology and rolling up based on spend, etc., estimating the size of the market, and distributing among the geographic and/or product segments.

The top-down approach is mainly used for new product forecasting and the bottom-up approach is used for demand estimation of any product for different countries summed up to form the total market. We are able to round off insights and build stronger forecasts because we always do both these methods and triangulate the final numbers.

The study on the market covers the analysis of the leading geographies such as Asia-Pacific, Africa, Europe, Middle East, North America, and  Latin America for the period of 2022 to 2030. The qualitative analysis covers the industry landscape and trends, market opportunities, competitive landscape, and policy and regulatory scenario, and the quantitative analysis covers different market estimates and forecasts.

Data Triangulation & Validation:

Data triangulation of various sources and results of the research are carried out by benchmarking with reliable sources such as industry statistics, statistical databases, and company-level averages, etc.

We make sure to finalize the numbers in alignment with the market research. Firstly, our internal experts ensure thorough validation and checking to ensure accurate and precise analysis and then validation is also done using a multiple-data analysis model. Two-level validation is done and entails the finalization of the report scope and the way of representation pattern.

 

 

Stage III: Interpretation and Presentation

Analysis & Interpretation: The information gathered is then analyzed and synthesized. The second series of interviews are done if necessary to check and validate. The future opportunities are analyzed by understanding product commercialization and many other factors. It also comprises the analysis of data discrepancies observed across various data sources. Information procured from secondary and primary results is then, interpreted by considering the following parameters: (a partial list)

  • Establishing market drivers and trends
  • Analyzing the regulatory landscape to understand future growth
  • Market Segment based analysis to obtain revenue/volume
  • ​Analyzing current needs and determining penetration to estimate the market

Insights: Our reports deliver actionable insights backed with supporting facts and figures to assist you in achieving exemplary growth. Our in-depth analyses are interspersed with relevant insights and statistics to offer an executive-level view of a given market. The description helps in correlating many minor factors affecting the market and their impact on the different segments within the market.

Data curated from the analysis and interpretation are drawn to portray all in one consolidated report.

Presentation & Reporting: The market research report is presented in different forms such as charts by using a scientific approach for easy understanding. Historic, current, and future analysis is provided for each market in terms of both value and volume. The size of the market is interpreted in the US Dollar value and the respective unit, based on the product, for volume consumption.

The foreign exchange rates are calculated on the respective dates and for the respective regions covered in the study.

To request a free sample copy of this report, please complete the form below.


We value your inquiry and offer free customization with every report to fulfil your exact research needs.


This report addresses

  • Intelligent insights to take informed business decisions
  • Qualitative, acute and result oriented market analysis
  • Market size and forecasts from 2022 to 2030
  • Opportunities for expansion and in-depth market analysis
  • Segmentation and regional revenue forecasts
  • Analysis of the market share and competitive landscape
  • Strategic Recommendations to chart future course of action
  • Comprehensive Market Research Report in PDF and PPT formats

Need more?

  • Ask our analyst how this study was put together to learn more
  • Discuss additional requirements as part of the free customisation
  • Add more countries or regions to the scope 
  • Get answers to specific business questions 
  • Develop the business case to launch the product
  • Find out how this report may influence your business revenue
Last updated on: 09 April 2024
Updated by: Keta Vora

Related reports (by category)


Related reports (by geography)


subscribe to our newsletter
up